For longer-term investors, Hedgeye’s healthcare analyst team has its eyes on several names that could result in outsized returns on the long and short side over the next two or three years.
Here are two call-outs from Healthcare analyst Andrew Freedman:
- Teledoc (TDOC) is “a really good growth story”
- Zimmer Biomet Holdings (ZBH) is “really interesting over the next three years.”
Watch the full clip above for more ideas.